Welcome to the international HTA database

Showing [23806 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Olopatadine for the treatment of allergic conjunctivitis: a review of the clinical efficacy, safety, and cost-effectiveness
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Dovitinib for metastatic renal cell carcinoma
2012	Agency for Healthcare Research and Quality (AHRQ)	Primary care relevant interventions for tobacco use prevention and cessation in children and adolescents: a systematic evidence review for the U.S. Preventive Services Task Force
2012	Institute of Health Economics (IHE)	The safety and efficacy/effectiveness of using automated testing devices for universal newborn hearing screening: an update
2012	National Institute for Health and Care Excellence (NICE)	Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis. NICE technology appraisal guidance 254
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Diagnosis and treatment of pineal gland cysts: a review of the clinical effectiveness and guidelines
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Enobosarm (Ostarine) for cachexia in patients with advanced non-small cell lung cancer – first line
2012	Agency for Healthcare Research and Quality (AHRQ)	Screening for HIV in pregnant women: systematic review to update the U.S. Preventive Services Task Force Recommendation.
2012	National Institute for Health and Care Excellence (NICE)	Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation. NICE technology appraisal guidance 256
2012	HAYES, Inc.	Esteem Totally Implantable Hearing System (Envoy Medical Corp.) for treatment of moderate to severe sensorineural hearing loss in adults
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Congestive heart failure follow-up models: a review of the clinical effectiveness
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Enzastaurin for diffuse large B-cell lymphoma – following complete remission
2012	Agency for Healthcare Research and Quality (AHRQ)	Screening for HIV: systematic review to update the U.S. Preventive Services Task Force Recommendation
2012	National Institute for Health and Care Excellence (NICE)	Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2. NICE technology appraisal guidance 257
2012	NIHR Health Technology Assessment programme	Management of frozen shoulder: a systematic review and cost-effectiveness analysis
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Double gloves for prevention of transmission of blood borne pathogens to patients: a review of the clinical evidence
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Everolimus (Afinitor) for advanced, unresectable or metastatic neuroendocrine tumours
2012	Agency for Healthcare Research and Quality (AHRQ)	Challenges in synthesizing and interpreting the evidence from a systematic review of multifactorial interventions to prevent functional decline in older adults
2012	National Institute for Health and Care Excellence (NICE)	Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer. NICE technology appraisal guidance 258
2012	NIHR Health Technology Assessment programme	The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders
2012	NIHR Health Technology Assessment programme	Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Immune response to hepatitis B vaccination: a review of the clinical evidence
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Nanoliposomal irinotecan for metastatic pancreatic cancer in patients who have progressed on prior gemcitabine-based therapy
2012	Agency for Healthcare Research and Quality (AHRQ)	Menopausal hormone therapy for the primary prevention of chronic conditions: systematic review to update the 2002 and 2005 U.S. Preventive Services Task Force Recommendations.
2012	National Institute for Health and Care Excellence (NICE)	Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen. NICE technology appraisal guidance 259
2012	HAYES, Inc.	Genesis II total knee system with oxinium femoral implants (Smith and Nephew Inc.) for total knee arthroplasty
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Medication reconciliation at discharge: a review of the clinical evidence and guidelines
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Ofatumumab (Arzerra) for maintenance treatment in relapsed chronic lymphocytic leukaemia (CLL) patients responding to induction therapy
2012	Agency for Healthcare Research and Quality (AHRQ)	Screening women for intimate partner violence and elderly and vulnerable adults for abuse: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation.
2012	National Institute for Health and Care Excellence (NICE)	Botulinum toxin type A for the prevention of headaches in adults with chronic migraine. NICE technology appraisal guidance 260
2012	NIHR Health Technology Assessment programme	Abatacept for the treatment of rheumatoid arthritis after the failure of conventional disease-modifying antirheumatic drugs
2012	HAYES, Inc.	Glucarpidase (Voraxaze; BTG International Ltd.) for treatment of high-dose methotrexate-induced nephrotoxicity
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Day programming for post-traumatic stress disorder: a review of the clinical effectiveness, cost-effectiveness and guidelines
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Pomalidomide for multiple myeloma – third line
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Day surgery: a systematic overview]
2012	National Institute for Health and Care Excellence (NICE)	Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism. NICE technology appraisal guidance 261
2012	National Institute for Health and Care Excellence (NICE)	Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M. NICE diagnostics guidance 6
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	AmniSure versus fern testing to assess the rupture of fetal membranes in pregnant women: a review of the comparative accuracy, cost-effectiveness, and guidelines
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Velimogene aliplasmid (Allovectin) for advanced or metastatic malignant melanoma
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Trametinib for advanced or metastatic BRAF V600E mutation-positive melanoma
2012	Agency for Healthcare Research and Quality (AHRQ)	Treatment for restless legs syndrome
2012	National Institute for Health and Care Excellence (NICE)	Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer. NICE technology appraisal guidance 263
2012	National Institute for Health and Care Excellence (NICE)	SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver. NICE diagnostics guidance 5
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Procedure site bleeding complications following percutaneous coronary interventions or angioplasty: a review of clinical evidence and guidelines
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Vinflunine (Javlor) monotherapy for advanced breast cancer
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Avastin® for age-related macular degeneration]
2012	Agency for Healthcare Research and Quality (AHRQ)	Strategies to reduce cesarean birth in low-risk women
2012	National Institute for Health and Care Excellence (NICE)	Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours. NICE technology appraisal guidance 265
2012	National Institute for Health and Care Excellence (NICE)	Laparoscopic gastric plication for the treatment of severe obesity. NICE interventional procedures guidance 432
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Codeine and acetaminophen for pain relief: a review of the clinical efficacy and safety
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Cangrelor to reduce platelet aggregation and thrombosis in patients undergoing percutaneous coronary intervention
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	IFEDH - Innovative Framework for Evidence Based Decision Making in Health Care: Standards on how to parameterise models via published literature: Input of the LBI-HTA (WP 4.2)
2012	Agency for Healthcare Research and Quality (AHRQ)	Comparison of characteristics of nursing homes and other residential long-term care settings for people with dementia
2012	National Institute for Health and Care Excellence (NICE)	Mannitol dry powder for inhalation for treating cystic fibrosis. NICE technology appraisal guidance 266
2012	National Institute for Health and Care Excellence (NICE)	Percutaneous laser atherectomy as an adjunct to balloon angioplasty (with or without stenting) for peripheral arterial disease. NICE interventional procedures guidance 433
2012	The Swedish Council on Health Technology Assessment (SBU)	[Blood test for early diagnosis of Alzheimer's disease]
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Point-of-care testing: a review of systematic reviews on testing accuracy and cost-effectiveness
2012	NIHR Horizon Scanning Centre (NIHR HSC)	SAR236553/REGN727 for the reduction of elevated total cholesterol and low density lipoprotein cholesterol
2012	Agency for Healthcare Research and Quality (AHRQ)	Procalcitonin-guided antibiotic therapy
2012	National Institute for Health and Care Excellence (NICE)	Ivabradine for treating chronic heart failure. NICE technology appraisal guidance 267
2012	National Institute for Health and Care Excellence (NICE)	Radiofrequency cold ablation for respiratory papillomatosis. NICE interventional procedures guidance 434
2012	HAYES, Inc.	Hysteroscopic morcellation (Truclear Morcellator System; Smith & Nephew Inc.) for treatment of uterine submucosal fibroids and endometrial polyps
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Opioid management practices for the prevention of drug diversion and misuse: a review of the clinical evidence and guidelines
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Spartan RX™ point-of-care DNA test for identifying the CYP2C19*2 mutation
2012	Agency for Healthcare Research and Quality (AHRQ)	Physical therapy interventions for knee pain secondary to osteoarthritis
2012	National Institute for Health and Care Excellence (NICE)	Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma. NICE technology appraisal guidance 268
2012	National Institute for Health and Care Excellence (NICE)	Endovascular stent insertion for intracranial atherosclerotic disease. NICE interventional procedures guidance 429
2012	Agency for Healthcare Research and Quality (AHRQ)	Reliability testing of the AHRQ EPC approach to grading the strength of evidence in comparative effectiveness reviews
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Abuse and misuse potential of pregabalin: a review of the clinical evidence
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO®) impulse system for acute coronary syndromes including heart attack
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Hyperthermia in breast-, bladder-, cervix carcinoma and soft tissue sarcoma patients
2012	Agency for Healthcare Research and Quality (AHRQ)	Treatment for hepatitis C virus infection in adults
2012	National Institute for Health and Care Excellence (NICE)	Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma. NICE technology appraisal guidance 269
2012	National Institute for Health and Care Excellence (NICE)	Partial replacement of the meniscus of the knee using a biodegradable scaffold. NICE interventional procedures guidance 430
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Clofarabine (Evoltra) for acute myeloid leukaemia in older adults unsuitable for anthracycline-based combination chemotherapy
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Newborn screening for cystic fibrosis: a review of the clinical and cost-effectiveness
2012	NIHR Horizon Scanning Centre (NIHR HSC)	SCOUT DS® and Diab-spot for type 2 diabetes screening
2012	Agency for Healthcare Research and Quality (AHRQ)	Progestogens for prevention of preterm birth
2012	National Institute for Health and Care Excellence (NICE)	Decitabine for the treatment of acute myeloid leukaemia (terminated appraisal). NICE technology appraisal guidance 270
2012	National Institute for Health and Care Excellence (NICE)	Percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillation. NICE interventional procedures guidance 427
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Periostat for periodontal disease: a review of the clinical effectiveness, cost effectiveness and guidelines
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Faldaprevir with BI 207127 for chronic hepatitis C infection, genotype 1
2012	Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS )	[Efficacy and safety of ornithine in treating hyperammonemia from acute and chronic liver diseases]
2012	Agency for Healthcare Research and Quality (AHRQ)	Screening for hepatitis C virus infection in adults
2012	National Institute for Health and Care Excellence (NICE)	Focal therapy using cryoablation for localised prostate cancer. NICE interventional procedures guidance 423
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pharmacologic smoking cessation interventions for patients with cardiovascular conditions: a review of the safety and guidelines
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Secukinumab for active and progressive psoriatic arthritis
2012	Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS )	[Efficacy and safety of the artificial urinary sphincter (AS) in treating postprostatectomy urinary incontinence]
2012	Agency for Healthcare Research and Quality (AHRQ)	Screening, behavioral counseling, and referral in primary care to reduce alcohol misuse
2012	National Institute for Health and Care Excellence (NICE)	Micropressure therapy for refractory Ménière's disease. NICE interventional procedures guidance 426
2012	NIHR Health Technology Assessment programme	A pilot randomised controlled trial in intensive care patients comparing 7 days' treatment with empirical antibiotics with 2 days' treatment for hospital-acquired infection of unknown origin
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Watchful dosing of morphine or morphine equivalent dosing in the treatment of chronic non-cancer pain: a review of the clinical evidence
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Secukinumab for ankylosing spondylitis – second line
2012	Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS )	[Efficacy and safety of tocilizumab in treating rheumatoid arthritis]
2012	Agency for Healthcare Research and Quality (AHRQ)	First-generation versus second-generation antipsychotics in adults: comparative effectiveness.
2012	National Institute for Health and Care Excellence (NICE)	Incisionless otoplasty. NICE interventional procedures guidance 422
2012	NIHR Health Technology Assessment programme	Abiraterone acetate for the treatment of metastatic, castrate-resistant prostate cancer following previous cytotoxic chemotherapy
2012	Canadian Agency for Drugs and Technologies in Health (CADTH)	Opioid trial periods for management of chronic non-cancer pain: a review of clinical effectiveness, guidelines and recommendations
2012	NIHR Horizon Scanning Centre (NIHR HSC)	UPDATED: Alair® bronchial thermoplasty system for severe asthma
2012	Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS )	[Uterine artery embolization in patients aiming to preserve the uterus]